Efficacy and Safety of a Parenteral Nutrition Program for Patients with RAS Wild-Type Metastatic Colorectal Cancer Administered First-Line Cetuximab Plus Chemotherapy: A Propensity Score Matching Study.
Nutrients
; 15(13)2023 Jun 30.
Article
in En
| MEDLINE
| ID: mdl-37447297
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Rectal Neoplasms
/
Colorectal Neoplasms
/
Colonic Neoplasms
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Nutrients
Year:
2023
Document type:
Article
Affiliation country:
Taiwán
Country of publication:
Suiza